Vaccine Center Research
Researchers at NYU Langone’s Vaccine Center use state-of-the-art methods to tackle complex problems in vaccine research. Our basic science and clinical research studies are designed to produce innovative new vaccines and devise ways to make their delivery painless and effective.
Around the world, communities are devastated by influenza, tuberculosis, malaria, and HIV/AIDS, conditions that are resistant to many existing drugs and targeted vaccines. Our challenge is to find new ways to combat these diseases and to identify safe, broadly effective vaccines that can make a powerful difference in global health.
We also focus on developing novel vaccines for nonviral and nonmicrobial illnesses including Alzheimer’s disease, autoimmune diseases, opioid use disorder, cancers, and other chronic conditions.
Beyond vaccine development, we lead research projects to develop new diagnostics and predictive markers to help providers detect disease early and predict the effectiveness of inoculation.
Active Clinical Studies
The Vaccine Center has ongoing studies that support future vaccine trials and studies of the human immune system and infectious diseases. This research builds on prior studies of the human immune response to infections and offers deeper insight into the complexity of these responses. It also holds possibilities for the development of rapid responses to emerging infectious threats.
If you are interested in enrolling, please email us at firstname.lastname@example.org.
Phase 3 Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
Phase 1/2 Placebo-Controlled Randomized Observer-Blind Dose-Finding Study to Describe the Safety Tolerability Immunogenicity and Potential Efficacy of SARS-CoV-2 RNA Vaccine Candidates Against COVID-19 in Healthy Adults
Multicenter Adaptive Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
Phlebotomy of Healthy Adults for the Purpose of Evaluation and Validation of Immune Response and Microbiology Assays
Specimen Collection for Infectious Diseases with Public Health Importance
Randomized Phase 2 Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection (CONSORTIUM)
Our Research Facilities
The Vaccine Center has basic research and clinical spaces in multiple NYU Langone research facilities.
Vaccine Center labs and clinical spaces are located in the following facilities:
- NYU Langone Hospital—Brooklyn
- NYU Winthrop Hospital
- VA NY Harbor Healthcare System
- NYC Health + Hospitals/Bellevue
- Schwartz Health Care Center: research clinic
- Medical Science Building: specimen-processing laboratory and biospecimen repository
- Alexandria Center for Life Sciences: research laboratories and administrative space